Antonio Filosa Report Card: Stellantis Turnaround in Review
A year after taking the helm at Stellantis, Antonio Filosa faces a mixed bag: a Q1 2026 earnings beat, a historic 202...
Which Dividend Etf Is Cheapest To Own
Compare ownership costs across dividend ETFs to identify which option offers the best balance of cost, yield, and risk.
22,825 articlesThree Overlooked U.S. Value Stocks Poised to Outperform 2026
A trio of overlooked U.S. value stocks combines strong balance sheets with cheap earnings multiples, making them cand...
Why Paying Your Mortgage Early Might Backfire in Retirement
Retirees are rethinking a longtime rule of thumb: pay off the mortgage before retirement. With rates higher and marke...
Tsunami Seniors: Record Numbers Reshape Investing Landscape
As millions of Baby Boomers retire, a fundamental shift is underway for markets and investment strategies. This story...
Strategy Plans to Sell $1.25B in Bitcoin to Calm Investors
Strategy reveals a potential strategy sell $1.25 billion in Bitcoin to strengthen liquidity and investor confidence a...
Prediction: Pivoting Away From Metaverse Could Lift META
Meta is dialing back its grand metaverse bet. This pivot could reshape the company’s profits and the stock’s long-run...
This Gold-Standard Forecaster Predicted 4.2% Inflation: Next
A trusted economics forecaster nailed a 4.2% inflation reading months ahead of the Federal Reserve. Now, they offer a...
Trinity Capital Roller Coaster: 14% Venture Lending Yield
Trinity Capital remains a high-yield fixture in venture lending, but a balance of losses, dilution, and rate shifts u...
International Small Caps Deliver Gains with Dividends
International small caps have surged about 35% over the past year as value and profitability themes take hold in deve...
PennantPark’s Yield Partly Funded; Reserve Nears End
PennantPark pays an about 20% yield through an $0.08 monthly payout, but a spillover reserve backs part of the divide...
This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Longbridge Sets Record, Surpasses Q1 Profit Milestone
Longbridge's Q1 results set a quarterly high and eclipsed its 2025 full-year profit, highlighting strong reverse-mort...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status